维普中文期刊产品整合服务
43篇 您的检索式:作者名="Kaur IP"
    题名 作者 年代 出处 被引量
1Nanotherapy for posterior eye diseases 显示文摘Kaur IP Kakkar S 2014J Controlled Release2014,193,:1
2Improved pharmacodynamics of timolol maleate from a mucoadhesiv niosomal ophthalmi drug delivery system显示文摘Aggarwal D Kaur IP 0,,:1
3Improved pharmacodynamics of timolol maleate from a mucoadhesive niosomal ophthalmic drug delivery system显示文摘Aggarwal D Kaur IP 0,,:1
4Pharmacokinetics, tissue distribution and relative bioavailability of isoniazid-sohd lipid nanoparticles 显示文摘Bhandari R Kaur IP 2013Int J Pharm2013,441,12:1
5Improved pharmacodynamics of timololmaleate from a mucoadhesive niosomat ophthalmic drug delivery system显示文摘AGGARWAL D KAUR IP 2005Int J Pharm2005,290,16:1
6Improved pharmaeodynamics of timolol maleate form a mucoad-hesive niosomal ophthalmic drug deliv ery system显示文摘Aggarwal D Kaur IP 2005Int J Pharm2005,290,1:1
7Inhibition of Mutagenicity of Food - Derived Heterocydic Amines by Sulforaphene- an Isothiocyanate Isolated from Radish显示文摘Shishu Singla AK Kaur IP 2003Planta Med2003,69,2:1
8Probiotics:delineation of prophylactic and therapeutic benefits显示文摘KAUR IP KUHAD A GARG A 2009J Med Food2009,12,2:1
9Penetration enhancers and ocular bioadhesives: two new avenues for ophthalmic drug delivery 显示文摘Kaur IP Smitha R 2002Drug Der Ind Pharm2002,28,4:1
10Improved pharmacodynamics of timolol maleate from a mucoadhesive niosomal ophthalmic drug delivery system 显示文摘Aggarwal D Kaur IP 2005Int J Pharm2005,290,16:1
11Ocular preparations: the formulation approach显示文摘Kaur IP Kanwar M 2002Drug Dev IndPharm2002,28,5:1
12Improved pharmacodynamics of timolol maleate from a mucoadhesive niosomal ophthalmic drug delivery system显示文摘Aggarwal D Kaur IP 2005Int J Pharm2005,290,12:1
13Vesicular systems in ocular drug delivery:an overview显示文摘 Garg A Singla AK 2004Int J Pharm2004,269,:1
14Formulation and evaluation of ophthalmic preparations of acetazolamide显示文摘Kaur IP Singh M Kanwar M 2000Ira J Pharm2000,199,2:1
15Improved pharmacodynamics of timolol maleate from a mucoadhesive niosomal ophthalmic drug delivery system显示文摘Aggarwal D Kaur IP 2005Ira J Pharm2005,290,12:1
16Improved pharmacodynamics of timolol maleate from a mucoadhesive niosomal ophthalmic drug delivery system显示文摘Aggarwal D Kaur IP 2005Int J Pharm2005,290,16:1
17Nanotherapy for posterior eye diseases 显示文摘Kaur IP Kakkar S 2014J Control Release2014,193,10:1
18Potential of solid lipid nanoparticles in brain targeting显示文摘Kaur IP Bhandari R Bhandari S 2008J Control Release2008,127,2:1
19Improved pharmacodynamics of timolol maleate from a mucoadhesive niosomal ophthalmic drug delivery system显示文摘Aggarwal D Kaur IP 2005Int J Pharm2005,290,12:1
20Ocular preservatives:associated risks and newer options显示文摘Kaur IP Lal S Rana C 2009Cutan Ocul Toxicol2009,28,:1
返回顶部 每页显示:
共3页 首页 上一页 第1页 下一页 末页 /3 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费